- Home
- JSPR vs DTF Comparison
JSPR vs DTF Comparison
Compare JSPR & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JSPR | DTF |
|---|---|---|
| Founded | 2018 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.4M | 79.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JSPR | DTF |
|---|---|---|
| Price | $1.81 | $11.39 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $25.60 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 21.1K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.64% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.39 | $10.29 |
| 52 Week High | $23.11 | $11.19 |
Technical Indicators
Market Signals| Indicator | JSPR | DTF |
|---|---|---|
| Relative Strength Index (RSI) | 46.29 | 52.33 |
| Support Level | $1.60 | $11.33 |
| Resistance Level | $1.93 | $11.44 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 36.90 | 52.97 |
Price Performance
Historical ComparisonAbout JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.